DEBx Medical and DEBRICHEM featured on Bioworld MedTech

Last Friday, a new article about DEBx Medical and our product DEBRICHEM was published online on Bioworld Medtech. The article states, among other things, that we have advanced to the pre-launch phase for our new topical desiccant gel for the treatment of chronic infected and necrotic wounds. Two months after obtaining CE mark approval for DEBRICHEM, we are now starting distribution of our class IIb medical device in Europe – in the Netherlands, Italy and Spain – as well as in Hong Kong, South Africa, New Zealand and Australia. 

Curious about what else the journalist had to say about our company and product?

Click here to get access to the full article.

More Posts

In Depth: Debridement

The presence of a biofilm in a wound is known to be detrimental to wound healing as is the case with the presence of necrosis

In Depth: Biofilms

Virtually all wounds contain bacteria but the type and number of bacteria, their phenotype, as well as the way they are organized determine to what

Get in touch

welcome.

Login to get access to our case reports.

im_debx-medical_logo

Login to your account